Genzyme Corporation is a biotechnology company. The Company operates in six units. Renal develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure. Therapeutics develops, manufactures and distributes therapeutic... more

Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company that discovers, develops and commercializes therapeutics in areas of unmet medical need. The Company has United States and international commercial sales operations, with marketing subsidiaries in Australia, Austria, Canada,... more

Callisto Pharmaceuticals, Inc. (Callisto) is a biopharmaceutical company focused primarily on the development of drugs to treat neuroendocrine cancer (including advanced carcinoid cancer), acute leukemia and gastrointestinal disorders and diseases. The Company’s lead drug candidate,... more

QLT Inc. is a global biopharmaceutical company with two commercial products, Visudyne and Eligard, which were derived from its two technology platforms, photodynamic therapy and Atrigel. The Company's research and development efforts are focused on pharmaceutical products in the fields of... more

Trimeris, Inc. is a biopharmaceutical company primarily engaged in the commercialization of a class of antiviral drug treatments called fusion inhibitors for use in human immunodeficiency virus (HIV) treatment. FUZEON is the Company's first-generation HIV fusion inhibitor, developed in... more

Isotechnika Inc. (Isotechnika) is an international biopharmaceutical company. The Company’s primary business is the development of immunosuppressive drugs. In addition, the Company operates a diagnostic business segment. The diagnostic segment is operated through its wholly owned... more

Accentia BioPharmaceuticals, Inc (Nasdaq:ABPI) is a vertically-integrated specialty biopharmaceutical company, formed by the Hopkins Capital Group, LLC and affiliates to acquire late-stage targeted therapeutics and to use patented delivery technologies to enhance the performance of these... more

Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The Company is developing product candidates to treat a range of cancers using tumor... more

GenoMed's broad-spectrum anti-viral approach was specifically mentioned in BioShield II, recently introduced in the US Senate (see Section 2151 of Senate bill S. 975).

Cytochroma Inc. is a development stage specialty pharmaceutical company focused on the treatment and prevention of disorders related to Vitamin D insufficiency. The Company has a portfolio of therapeutics with lower development risk for the indications of Vitamin D insufficiency and for... more

IBEX Technologies, Inc. (IBEX) is a biopharmaceutical company engaged in the production and sale of enzymes for use as reagents in hemostasis monitoring devices, and of arthritis diagnostic kits for pharmaceutical research. It is principally engaged in the production and sale of... more

Advanced Viral Research Corp. (Advanced Viral) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions. The Company's products may be useful for the treatment... more

Verona Pharma plc is a life sciences company focused on the research, discovery and development of new therapeutic drugs for the treatment of allergic rhinitis (hay fever) and other chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), as well as... more

Salmedix is an oncology drug development company with a commercial focus on the treatment of hematologic malignancies, or blood cancers. TreandaÔ, also designated as SDX-105, our lead product candidate, has been marketed by others in Germany for many years, primarily for the treatment of... more

The F2G science team is supported by a management group which brings many years of experience from the world of finance and the Pharmaceutical Industry.

DNA Sciences, Inc. is focused on the discovery and commercialization of gene-based clinical tests that can determine disease susceptibility, predict disease progress and more effectively manage disease treatment. DNA Sciences collaborates with physicians, researchers and individuals to... more

Protalex, Inc. is a development stage company engaged in developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases. The Company’s lead product, PRTX-100, has demonstrated effectiveness in pre-clinical studies in regulating the immune system with... more

Optimata Ltd. is a privately held bio-pharmaceutical company aiming at accelerating the long and costly process of drug development. Our innovative solution, Optimata Virtual Patient, is a biomathematics-based predictive software, enabling enhanced navigation of drug development towards a... more

Phylogix, Inc. is an early-stage biotechnology company developing an innovative class of lectin-based therapeutic drugs focused on tissue protection and oncology. The Company has a lead drug candidate in preclinical development, called FRIL, that addresses a critical unmet need to... more

Collgard Biopharmaceuticals, the tissue therapeutics company, is developing drug treatments that target disease progression by directly influencing the tissue regeneration process. Central to Collgard's novel approach is its lead drug candidate, Tempostatin (Halofuginone hydrobromide).... more

Curidium Medica Plc (Curidium) is engaged in the development and commercialization of companion diagnostics and targeted medicines to treat patients. The Company has operations in the United Kingdom of Great Britain and Northern Ireland. Curidium’s initial focus on diseases of the Central... more

LineaGen, Inc. (http://www.LineaGen.com) is a content-based biomarker discovery company focused on the commercialization of novel, patentable diagnostic tests that enable effective personalized medicine and healthcare. One of LineaGen's core competitive advantages is its access to an... more

BioRelix Pharmaceuticals, Inc. is a drug discovery and development company focused on identifying new anti-infective drug treatments. BioRelix is building a portfolio of anti-infective products based on novel patented RNA targets, termed RiboSwitches, which were identified in the... more

LymphoSign is developing a number of novel compounds discovered in the laboratory of Dr. Chaim Roifman, the company's founder, at The Hospital for Sick Children, Toronto. These compounds inhibit abnormal cellular signalling specific to the growth of cancer cells. LymphoSign's lead drug... more

Tekmira Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer and other diseases.

Cognitive Pharmaceuticals was established in 2001 based on a proprietary platform technology developed at the University of Toledo, College of Pharmacy, and in April 2003 was registered in Michigan as a for-profit organization [www.medc.michigan.org] [www.michbio.org]. Emphasis is on... more

Rhinopharma Ltd is a newly formed company dedicated to finding new drug treatments for rhinitis and other respiratory diseases. In the first phase of research strategy Rhinopharma is searching for new drugs for allergic rhinitis that can be rapidly brought to clinical trial. A longer term... more